RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
Clinical trial NCT06491862 · RECRUITING
Trial details
- NCT number
- NCT06491862
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-25
- Primary completion
- 2026-12-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.